The same is true for uterine cancer, since antiprogestins, Tamoxifen, and aromatase inhibitors are also commonly used for its treatment, and estrogen responsiveness is a sign of a more differentiated phenotype.32 Here, CYP19A1 is linked to uterine cancer.